To: Kadlec, Robert (OS/ASPR/IO); Conrad, Patricia (NIH/NIAID) [E]; Collins, Francis (NIH/OD) [E];
r__()(6}: Dareshori, Zack (HHS/IOS); Bright, Rick (OS/ASPR/BARDA); Disbrow, Gary
(OS/ASPR/BARDA); Ford-Barnes, Arwenthia (OS/ASPR/IO); Blatner, Gretta (OS/ASPR/BARDA);
Patrick, Vanessa (OS/ASPR/BARDA) (CTR); Moughalian, Jen (HHS/ASFR); Shuy, Bryan
(OS/ASPR/IO); Redd, John (OS/ASPR/SPPR); Tignor, Beth (HHS/IOS); Redfield, Robert R.
(CDC/OD); Strength-McGaughey, Tracie (CDC/DDNID/NCIPC/OD); Hassell, David (Chris)
(OS/ASPR/IO); Yeskey, Kevin (OS/ASPR/IO); Callahan, Victoria (OS/ASPR/IO) (CTR); Moreno,
Rafael (OS/ASPR); Marks, Peter (FDA/CBER); Cochran, Norris (HHS/ASFR); Messonnier, Nancy
(CDC/DDID/NCIRD/OD); Windom, Robert (OS/ASPR/IO); Lane, Cliff (NIH/NIAID) [E]; Holland,
Tara (OS/ASPR/EMMO); Johnson, Robert (OS/ASPR/BARDA); Gershman, Lynn E.
(CDC/DDPHSIS/OD); Kemp, Micha (OS/ASPR/MFHC); Lenihan, Keagan (FDA/OC); Mark Hartell
Mascola, John (NIH/VRC) [E]; Suhana, Tina (NIH/VRC) [E]:
Marston, Hilary (NIH/NIAID) [E]; Fauci, Anthony (NIH/NIAID) [E]
Subject: #2 - COVID-19 Advisory Panel
When: Wednesday, April 8, 2020 5:15 PM-6:30 PM (UTC-05:00) Eastern Time (US & Canada).
Where: WEBEx -[—_________0}

 

Presentation for Wednesday. 4:26pm

<< File: BARDA COVID Vaccines White Paper 20200405b.docx >>

Meeting Objective:

(1) Complete review of BARDA vaccine portfolio (to include related NIH and DoD programs), with emphasis on
discussion among Panel members;

(2) Formulate a recommendation to Secretary Azar to either endorse or modify current vaccine strategy, plans,
proposed funding and contracts.

Agenda
Brief review of vaccine programs

e BARDA (deeper dive after Sunday overview)

e NIAID
e DoD
Discussion

Recommendation to Secretary Azar

For convenience, below are the presentation and White Paper from last Sunday evening.
<< File: BARDA COVID Portfolio Review 20200405b.pptx >> << File: Vaccine Discussion with S1
and HHS Leadership V2 FINAL - Gary.pdf >>

Hi Arwenthia Ford-Bames,

You updated this WebEx meeting:

#2 COVID-19 Advisory Panel on behalf of Dr. Robert Kadlec
